🇺🇸 StrataGraft in United States
3 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 3
Most-reported reactions
- Application Site Infection — 1 report (33.33%)
- Treatment Failure — 1 report (33.33%)
- Wound Infection Staphylococcal — 1 report (33.33%)
Other Dermatology approved in United States
Frequently asked questions
Is StrataGraft approved in United States?
StrataGraft does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for StrataGraft in United States?
Stratatech, a Mallinckrodt Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.